Antitumor activity of carboplatin in the composition of a copolymer of lactic and glycolic acids
- Authors: Nikolskaya E.D.1, Zhunina O.A.1, Yabbarov N.G.1, Zenin V.A.1, Tereshchenko O.G.1, Fomicheva M.V.1, Sokol M.B.1, Lobanov A.V.2, Severin E.S.1
-
Affiliations:
- OJSC Russian Research Center for Molecular Diagnostics and Therapy
- N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences
- Issue: Vol 66, No 10 (2017)
- Pages: 1867-1872
- Section: Full Articles
- URL: https://ogarev-online.ru/1066-5285/article/view/241436
- DOI: https://doi.org/10.1007/s11172-017-1959-5
- ID: 241436
Cite item
Abstract
Polymer particles containing carboplatin (CPt) were developed by the inclusion of this antitumor agent in a copolymer of lactic and glycolic acids (PLGA-COOH 50/50). The polymer particles were found to have a spherical form with an average diameter not exceeding 200 nm, the ζ-potential is equal to–32.2±1 mV. The CPt-loaded polymer particles possess a cytotoxic activity against human small cell and non-small cell lung carcinoma (lines H69 and A549), as well as against mouse mammary adenocarcinoma (line Ca755). The results of the in vivo studies carried out on female mice of line C57Bl/6 with inoculated mouse melanoma of line B16 showed increasing of lifespan of the animals and inhibition of tumor growth for groups treated with the polymer particles, as compared to the animals treated with the drug substance CPt.
About the authors
E. D. Nikolskaya
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
O. A. Zhunina
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
N. G. Yabbarov
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
V. A. Zenin
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
O. G. Tereshchenko
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
M. V. Fomicheva
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
M. B. Sokol
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
A. V. Lobanov
N. N. Semenov Institute of Chemical Physics, Russian Academy of Sciences
Email: e.severin@mail.ru
Russian Federation, 4 ul. Kosygina, Moscow, 119991
E. S. Severin
OJSC Russian Research Center for Molecular Diagnostics and Therapy
Author for correspondence.
Email: e.severin@mail.ru
Russian Federation, 8 Simferopolsky bulvar, Moscow, 117638
Supplementary files
